Scholars Central

Conference abstract

Cyclodetrin-based nanoaggregates for eye drop formulations

Authors: Blanca Lorenzo-Veiga, Hakon Hrafn Sigurdsson, Thorsteinn Loftsson

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: Topical eye drops are the most common and convenient dosage form of the drug to the eye. Nevertheless, due to eye barriers, poor drug absorption and low bioavailability make the development of an optimal formulation a challenge. Different strategies have been proposed to address these problems. Cyclodextrin-based nanoaggregates have emerged in recent years as a new platform for drug delivery to the anterior and even posterior segment of the eye. Cyclodextrins are natural cyclic oligosaccharides that have the ability to form water-soluble inclusion complexes holding in their cavities lipophilic drug molecules as guests. The purpose of this study was to investigate the effect of three water-soluble polymers (PVP, PVA, and tyloxapol) widely used in eye drops formulations on the solubility of complexes containing a single CD(gamma-CD) or a mixture of CDs(gammaCD/ HPBetaCD) and nepafenac as a model drug. Methodology & Theoretical Orientation: The effect of these polymers on apparent solubility of the complex was analyzed by UHPLC. Moreover, size, osmolarity, and viscosity of these systems were analyzed. Findings: the addition of PVA led to the greatest increase in solubility in both single and mixture CDs. In the case of a single CD, the size was around 163-296 nm but in the case of mixtures of CDs, PVP and tyloxapol showed in some cases a size higher than 1μm. In all cases, the addition of these polymers led to an increase in the viscosity and osmolarity. Conclusion & Significance: This is the first time that the effect of different polymers on nepafenac/CD complexes using a mixture of CDs have been studied. Results showed that the addition of water-soluble polymers such as PVA, PVP or tyloxapol could be a good strategy for the formulation of eye drops containing nepafenac. Recent Publications 1. Lorenzo-Veiga B, Sigurdsson HH, Loftsson T. Nepafenac-Loaded Cyclodextrin/Polymer Nanoaggregates: A New Approach to Eye Drop Formulation. Materials (Basel, Switzerland). 2019;12(2). 2. Loftsson T, Stefansson E. Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye. Int J Pharm. 2017;531(2):413-23 3. Conceicao J, Adeoye O, Cabral-Marques HM, Lobo JMS. Cyclodextrins as Drug Carriers in Pharmaceutical Technology: The State of the Art. Current pharmaceutical design. 2018;24(13):1405-33. 4. Jacob S, Nair AB. Cyclodextrin complexes: Perspective from drug delivery and formulation. Drug development research. 2018;79(5):201-17. 5. Shelley H, Grant M, Smith FT, Abarca EM, Jayachandra Babu R. Improved Ocular Delivery of Nepafenac by Cyclodextrin Complexation. AAPS PharmSciTech. 2018;19(6):2554-63.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in American Journal of Advanced Drug Delivery.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAmerican Journal of Advanced Drug Delivery
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Blanca Lorenzo-Veiga”
  • BylineArticles whose byline prints “Hakon Hrafn Sigurdsson”
  • BylineArticles whose byline prints “Thorsteinn Loftsson”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels